Micra Leadless pacemaker implantation, Summaries of Cardiology

Leadless pacemaker implantation techniques for micra

Typology: Summaries

2025/2026

Uploaded on 06/13/2026

neet-aipg-newstips
neet-aipg-newstips 🇮🇳

13 documents

1 / 2

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Micra Leadless Pacemaker Implantation – Practical Stepwise
Overview
This document summarizes the practical procedural workflow, handle controls, locking mechanism, and
troubleshooting points during implantation of the Medtronic Micra leadless pacemaker system.
1. Femoral Venous Access
Right femoral venous access is commonly preferred. Initial puncture is often obtained using micropuncture technique
followed by serial dilation. Final introducer sheath size is approximately 27F outer diameter and 23F inner diameter.
Because the sheath is large, ultrasound-guided access and careful venous puncture are important to avoid vascular
complications.
2. Advancement of Sheath and Delivery System
A stiff guidewire such as an Amplatz Super Stiff wire is advanced into the SVC. The large introducer sheath is then
positioned into the right atrium. The Micra delivery catheter is advanced through the sheath into the RA, across the
tricuspid valve, and into the right ventricle.
3. Target Implant Position
Preferred implantation site is usually the RV septum or apical septal region. Free wall deployment should be avoided
because of perforation risk. Fluoroscopic RAO and LAO views help confirm septal positioning.
4. Main Controls on the Micra Delivery Handle
The delivery handle contains multiple control systems:
A. Deflection Control: Used to flex and steer the catheter toward the RV septum.
B. Deployment Mechanism: Used to deploy the nitinol fixation tines into myocardium.
C. Locking Button / Lock Switch: A safety mechanism that prevents accidental deployment or unintended release
of the device. It stabilizes the tether and deployment system during positioning and recapture. The lock essentially
keeps the system in a “safe” state until intentional deployment and release are desired.
5. Importance of the Locking Mechanism
The locking system prevents premature release of the device while the operator is still evaluating fixation and
electrical parameters. Before final release, the Micra remains attached to a tether and can still be recaptured and
repositioned.
pf2

Partial preview of the text

Download Micra Leadless pacemaker implantation and more Summaries Cardiology in PDF only on Docsity!

Micra Leadless Pacemaker Implantation – Practical Stepwise

Overview

This document summarizes the practical procedural workflow, handle controls, locking mechanism, and troubleshooting points during implantation of the Medtronic Micra leadless pacemaker system.

1. Femoral Venous Access

Right femoral venous access is commonly preferred. Initial puncture is often obtained using micropuncture technique followed by serial dilation. Final introducer sheath size is approximately 27F outer diameter and 23F inner diameter. Because the sheath is large, ultrasound-guided access and careful venous puncture are important to avoid vascular complications.

2. Advancement of Sheath and Delivery System

A stiff guidewire such as an Amplatz Super Stiff wire is advanced into the SVC. The large introducer sheath is then positioned into the right atrium. The Micra delivery catheter is advanced through the sheath into the RA, across the tricuspid valve, and into the right ventricle.

3. Target Implant Position

Preferred implantation site is usually the RV septum or apical septal region. Free wall deployment should be avoided because of perforation risk. Fluoroscopic RAO and LAO views help confirm septal positioning.

4. Main Controls on the Micra Delivery Handle

The delivery handle contains multiple control systems:

A. Deflection Control: Used to flex and steer the catheter toward the RV septum.

B. Deployment Mechanism: Used to deploy the nitinol fixation tines into myocardium.

C. Locking Button / Lock Switch: A safety mechanism that prevents accidental deployment or unintended release of the device. It stabilizes the tether and deployment system during positioning and recapture. The lock essentially keeps the system in a “safe” state until intentional deployment and release are desired.

5. Importance of the Locking Mechanism

The locking system prevents premature release of the device while the operator is still evaluating fixation and electrical parameters. Before final release, the Micra remains attached to a tether and can still be recaptured and repositioned.

6. Tug Test

After deployment, a gentle pull-and-hold maneuver (“tug test”) is performed. Ideally at least two tines should appear engaged before final release. Poor engagement requires recapture and repositioning.

7. Recapture

If thresholds are high, sensing is poor, or fixation is unstable, the device can be recaptured by advancing the recapture cone and pulling the tether. The Micra collapses back into the catheter and may be repositioned multiple times before final release.

8. Troubleshooting

Difficulty crossing tricuspid valve: Reduce deflection, withdraw slightly, rotate catheter, or use RA looping technique.

High thresholds: Reposition away from trabeculated or scarred regions.

Low sensing: Reposition away from scar or extreme apex.

Poor tug test: Do not release. Recapture and reposition.

Perforation warning signs: Hypotension, pericardial effusion, chest pain, or sudden instability during deployment.

9. Final Release

Final release is performed only after acceptable fixation, threshold, sensing, and impedance are confirmed. The tether is detached, the delivery system is removed, and femoral hemostasis is achieved.

Practical Concept:

Deliver → Position → Lock → Deploy → Tug Test → Assess Parameters → Recapture if

Needed → Final Release